GENCOR INDUSTRIES INC (GENC): Nasdaq/NYSE listing notice — Gencor receives NYSE American extension to Aug 19, 2025 to file delinquent reports

GENCOR INDUSTRIES INC

NYSE accepted extension request; new cure deadline August 19, 2025.
Delinquent reports: 10-K for FY ended Sep 30, 2024, and 10-Qs for Dec 31, 2024 and Mar 31, 2025.
Company expects to file 10-K within initial six-month period and 10-Qs by Aug 19, 2025.
Failure to make progress or file by Dec 30, 2025 could result in delisting.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GENCOR INDUSTRIES INC received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing
Rules: 1007

Exact text from the filing

June 24, 2025, the Company received a letter (the “Extension Notice”) from the NYSE, informing the Company that the NYSE accepted the extension request, granting the Company a plan period through August 19, 2025 (the “New Cure Deadline”) to submit its delinquent reports. NYSE staff will review the Company periodically for compliance with adherence to the milestones in the plan, and if the Company does not make progress consistent with the plan during the plan period or if the Company does not complete its delinquent reports by the end of the maximum 12-month cure period on December 30, 2025, N

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GENCOR INDUSTRIES INC filing history →

Source: SEC EDGAR

accession 0001193125-25-149714

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.